Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Neven

Showing results (81-90 of 140) with videos related to

Pageof 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2005
Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancerH J Huang, P Neven, M Drijkoningen, et al.
Acta Clinica Belgica|May 13, 2009
Trastuzumab treatment of early stage breast cancer is cost-effective from the perspective of the Belgian health care authoritiesI Van Vlaenderen, J L Canon, V Cocquyt, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 25, 2024
Expression patterns of H3K27me3 for differentiation of breast fibroadenomas and phyllodes tumorsE Slachmuylders, A Laenen, A Vernemmen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2013
The rs1800716 variant in CYP2D6 is associated with an increased double endometrial thickness in postmenopausal women on tamoxifenA-S Dieudonné, D Lambrechts, D Smeets, et al.
Breast Cancer Research and Treatment|May 9, 2019
Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survivalB M Aarts, E G Klompenhouwer, R C Dresen, et al.
Gynecologic Oncology|August 31, 2013
PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancerH Dauwen, B Van Calster, C M Deroose, et al.
Pathology Research International|January 22, 2011
Short-Term Prognostic Index for Breast Cancer: NPI or LpiV Van Belle, J Decock, W Hendrickx, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patientsL Morales, D Timmerman, P Neven, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 11, 2008
Clinicopathological features of inflammatory versus noninflammatory locally advanced nonmetastatic breast cancerB Brouwers, R Paridaens, J P Lobelle, et al.
Carcinogenesis|March 9, 1999
Lack of evidence from HPLC 32P-post-labelling for tamoxifen-DNA adducts in the human endometriumP L Carmichael, S Sardar, N Crooks, et al.
Pageof 14

Showing results (81-90 of 140) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2005
Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancerH J Huang, P Neven, M Drijkoningen, et al.
Acta Clinica Belgica|May 13, 2009
Trastuzumab treatment of early stage breast cancer is cost-effective from the perspective of the Belgian health care authoritiesI Van Vlaenderen, J L Canon, V Cocquyt, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 25, 2024
Expression patterns of H3K27me3 for differentiation of breast fibroadenomas and phyllodes tumorsE Slachmuylders, A Laenen, A Vernemmen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2013
The rs1800716 variant in CYP2D6 is associated with an increased double endometrial thickness in postmenopausal women on tamoxifenA-S Dieudonné, D Lambrechts, D Smeets, et al.
Breast Cancer Research and Treatment|May 9, 2019
Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survivalB M Aarts, E G Klompenhouwer, R C Dresen, et al.
Gynecologic Oncology|August 31, 2013
PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancerH Dauwen, B Van Calster, C M Deroose, et al.
Pathology Research International|January 22, 2011
Short-Term Prognostic Index for Breast Cancer: NPI or LpiV Van Belle, J Decock, W Hendrickx, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patientsL Morales, D Timmerman, P Neven, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 11, 2008
Clinicopathological features of inflammatory versus noninflammatory locally advanced nonmetastatic breast cancerB Brouwers, R Paridaens, J P Lobelle, et al.
Carcinogenesis|March 9, 1999
Lack of evidence from HPLC 32P-post-labelling for tamoxifen-DNA adducts in the human endometriumP L Carmichael, S Sardar, N Crooks, et al.
Pageof 14